Department of Colorectal Surgery, National Cancer Center Hospital, Tokyo, Japan.
Division of Frontier Surgery, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Cancer Med. 2021 Oct;10(20):6937-6946. doi: 10.1002/cam4.3972. Epub 2021 Sep 29.
In transitioning from the 7th edition of the tumor-node-metastasis classification (TNM-7) to the 8th edition (TNM-8), colorectal cancer with peritoneal metastasis was newly categorized as M1c. In the 9th edition of the Japanese Classification of colorectal, appendiceal, and anal carcinoma (JPC-9), M1c is further subdivided into M1c1 (without other organ involvement) and M1c2 (with other organ involvement). This study aimed to compare the model fit and discriminatory ability of the M category of these three classification systems, as no study to date has made this comparison.
The study population consisted of stage IV colorectal cancer patients who were referred to the National Cancer Center Hospital from 2000 to 2017. The Akaike information criterion (AIC), Harrell's concordance index (C-index), and time-dependent receiver operating characteristic (ROC) curves were used to compare the three classification systems. Subgroup analyses, stratified by initial treatment year, were also performed.
According to TNM-8, 670 (55%) patients had M1a, 273 (22%) had M1b, and 279 (23%) had M1c (87 M1c1 and 192 M1c2 using JPC-9) tumors. Among the three classification systems, JPC-9 had the lowest AIC value (JPC-9: 10546.3; TNM-7: 10555.9; TNM-8: 10585.5), highest C-index (JPC-9: 0.608; TNM-7: 0.598; TNM-8: 0.599), and superior time-dependent ROC curves throughout the observation period. Subgroup analyses were consistent with these results.
While the revised M category definition did not improve model fit and discriminatory ability from TNM-7 to TNM-8, further subdivision of M1c in JPC-9 improved these parameters. These results support further revisions to M1 subcategories in future editions of the TNM classification system.
从第 7 版肿瘤-淋巴结-转移(TNM-7)分期系统过渡到第 8 版(TNM-8)时,结直肠癌伴腹膜转移被重新归类为 M1c。在第 9 版日本结直肠、阑尾和肛门癌分类(JPC-9)中,M1c 进一步细分为 M1c1(无其他器官受累)和 M1c2(有其他器官受累)。本研究旨在比较这三种分类系统的 M 分期模型拟合度和判别能力,因为迄今为止尚无研究对此进行比较。
研究人群为 2000 年至 2017 年期间转诊至国家癌症中心医院的 IV 期结直肠癌患者。采用赤池信息量准则(AIC)、哈雷尔一致性指数(C-index)和时间依赖性接受者操作特征(ROC)曲线比较三种分类系统。还进行了按初始治疗年份分层的亚组分析。
根据 TNM-8,670 例(55%)患者为 M1a,273 例(22%)为 M1b,279 例(23%)为 M1c(87 例为 M1c1,192 例为 M1c2 根据 JPC-9)肿瘤。在这三种分类系统中,JPC-9 的 AIC 值最低(JPC-9:10546.3;TNM-7:10555.9;TNM-8:10585.5),C-index 最高(JPC-9:0.608;TNM-7:0.598;TNM-8:0.599),并且在整个观察期内的时间依赖性 ROC 曲线表现优越。亚组分析结果与这些结果一致。
虽然修订后的 M 分期定义并未提高从 TNM-7 到 TNM-8 的模型拟合度和判别能力,但 JPC-9 中 M1c 的进一步细分提高了这些参数。这些结果支持在未来的 TNM 分期系统版本中进一步修订 M1 亚分类。